Literature DB >> 20609955

More insights on the dysglycaemia-cardiovascular connection.

Hertzel C Gerstein1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609955     DOI: 10.1016/S0140-6736(10)60973-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?

Authors:  H C Gerstein
Journal:  Diabetologia       Date:  2010-11-20       Impact factor: 10.122

Review 2.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 3.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

4.  No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population.

Authors:  R Pfister; S J Sharp; R Luben; K-T Khaw; N J Wareham
Journal:  Diabetologia       Date:  2011-05-17       Impact factor: 10.122

5.  Does insulin resistance co-exist with glucocorticoid resistance in the metabolic syndrome? Studies comparing skin sensitivity to glucocorticoids in individuals with and without acanthosis nigricans.

Authors:  Surujpal Teelucksingh; Sarada Jaimungal; Lexley Pinto Pereira; Terence Seemungal; Shivananda Nayak
Journal:  Cardiovasc Diabetol       Date:  2012-03-30       Impact factor: 9.951

6.  Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women.

Authors:  Jennifer K Pai; Leah E Cahill; Frank B Hu; Kathryn M Rexrode; Joann E Manson; Eric B Rimm
Journal:  J Am Heart Assoc       Date:  2013-03-22       Impact factor: 5.501

7.  Change in HbA1c over 3 years does not improve the prediction of cardiovascular disease over and above HbA1c measured at a single time point.

Authors:  P Chamnan; R K Simmons; K T Khaw; N J Wareham; S J Griffin
Journal:  Diabetologia       Date:  2013-02-12       Impact factor: 10.122

8.  Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine?

Authors:  Hugo A Laviada-Molina; Irene Leal-Berumen; Ernesto Rodriguez-Ayala; Raul A Bastarrachea
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-07       Impact factor: 5.555

Review 9.  Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.

Authors:  Kannan Subbaram; P Shaik Syed Ali; Sheeza Ali
Journal:  Gene Rep       Date:  2022-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.